Multiple calcium channels and kinases mediate α7 nicotinic receptor neuroprotection in PC12 cells

被引:52
作者
Ren, K
Puig, V
Papke, RL
Itoh, Y
Hughes, JA
Meyer, EM
机构
[1] Univ Florida, Dept Pharmacol, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Pharmacol, Gainesville, FL USA
关键词
calcium; neuroprotection; alpha 7 nicotinic receptor; protein kinase;
D O I
10.1111/j.1471-4159.2005.03223.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
alpha 7 Nicotinic receptors are calcium permeant and provide neuroprotection against many insults. We investigated the roles of intracellular calcium ions and downstream calcium channels in this protection. The alpha 7 agonist GTS-21 prevented pheochromocytoma cell death induced by nerve growth factor + serum deprivation over a 3-day interval. This effect was blocked by the intracellular calcium chelator 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid in a manner that did not appear to involve changes in receptor density. 1,2-Bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid blocked GTS-21-induced protein kinase C activation, a necessary process for protection. The insositol triphosphate calcium-channel blocker xestospongin C and the phospholipases C inhibitor U-73122 blocked protection, ryanodine partially attenuated protection, but the L-type channel antagonist nifedipine had no effect. ERK1/2 but not JNK and p38 were activated by GTS-21, and the ERK phosphorylation inhibitors PD98059 and U0126 blocked protection.
引用
收藏
页码:926 / 933
页数:8
相关论文
共 42 条
[1]   MAPK recruitment by β-amyloid in organotypic hippocampal slice cultures depends on physical state and exposure time [J].
Bell, KA ;
O'Riordan, KJ ;
Sweatt, JD ;
Dineley, KT .
JOURNAL OF NEUROCHEMISTRY, 2004, 91 (02) :349-361
[2]   The versatility and universality of calcium signalling [J].
Berridge, MJ ;
Lipp, P ;
Bootman, MD .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2000, 1 (01) :11-21
[3]   Ventral hippocampal α7 nicotinic receptor blockade and chronic nicotine effects on memory performance in the radial-arm maze [J].
Bettany, JH ;
Levin, ED .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2001, 70 (04) :467-474
[4]   Moderate increases in intracellular calcium activate neuroprotective signals in hippocampal neurons [J].
Bickler, PE ;
Fahlman, CS .
NEUROSCIENCE, 2004, 127 (03) :673-683
[5]   Presence and functional significance of presynaptic ryanodine receptors [J].
Bouchard, R ;
Pattarini, R ;
Geiger, JD .
PROGRESS IN NEUROBIOLOGY, 2003, 69 (06) :391-418
[6]   Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo [J].
Briggs, CA ;
Anderson, DJ ;
Brioni, JD ;
Buccafusco, JJ ;
Buckley, MJ ;
Campbell, JE ;
Decker, MW ;
DonnellyRoberts, D ;
Elliott, RL ;
Gopalakrishnan, M ;
Holladay, MW ;
Hui, YH ;
Jackson, WJ ;
Kim, DJB ;
Marsh, KC ;
ONeill, A ;
Prendergast, MA ;
Ryther, KB ;
Sullivan, JP ;
Arneric, SP .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 57 (1-2) :231-241
[7]   Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusion [J].
Cooper, JD ;
Salehi, A ;
Delcroix, JD ;
Howe, CL ;
Belichenko, PV ;
Chua-Couzens, J ;
Kilbridge, JF ;
Carlson, EJ ;
Epstein, CJ ;
Mobley, WC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) :10439-10444
[8]   Intracellular Ca2+ signals evoked by stimulation of nicotinic acetylcholine receptors in SH-SY5Y cells:: contribution of voltage-operated Ca2+ channels and Ca2+ stores [J].
Dajas-Bailador, FA ;
Mogg, AJ ;
Wonnacott, S .
JOURNAL OF NEUROCHEMISTRY, 2002, 81 (03) :606-614
[9]   Nicotine activates the extracellular signal-regulated kinase 1/2 via the α7 nicotinic acetylcholine receptor and protein kinase A, in SH-SY5Y cells and hippocampal neurones [J].
Dajas-Bailador, FA ;
Soliakov, L ;
Wonnacott, S .
JOURNAL OF NEUROCHEMISTRY, 2002, 80 (03) :520-530
[10]   Characterisation of the binding of [3H]methyllycaconitine:: a new radioligand for labelling α7-type neuronal nicotinic acetylcholine receptors [J].
Davies, ARL ;
Hardick, DJ ;
Blagbrough, IS ;
Potter, BVL ;
Wolstenholme, AJ ;
Wonnacott, S .
NEUROPHARMACOLOGY, 1999, 38 (05) :679-690